EUVIMEDEUVIMED entdecken
Metaanalyse

Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a potential early biomarker for diabetic nephropathy: a meta-analysis

Praveen Prashant

International Journal of Biochemistry and Molecular Biology · 2024 · 15 (1) · 1-7

DOI: 10.62347/fvbs3902 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift International Journal of Biochemistry and Molecular Biology, 2024. Verfasst von Praveen Prashant. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Prashant, P. (2024). Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a potential early biomarker for diabetic nephropathy: a meta-analysis. International Journal of Biochemistry and Molecular Biology, 15(1), 1-7. https://doi.org/10.62347/fvbs3902

Vancouver

Prashant P. Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a potential early biomarker for diabetic nephropathy: a meta-analysis. International Journal of Biochemistry and Molecular Biology. 2024;15(1):1-7. doi:10.62347/fvbs3902

BibTeX
@article{Prashant2024,
  author = {Prashant, Praveen},
  title = {Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a potential early biomarker for diabetic nephropathy: a meta-analysis},
  journal = {International Journal of Biochemistry and Molecular Biology},
  year = {2024},
  volume = {15},
  number = {1},
  pages = {1--7},
  doi = {10.62347/fvbs3902}
}
Kostenlos starten →